Search clinical trials for: Salmeterol and Salmeterol / Fluticasone

Total 779 results

Aljazeera Hospital
Cairo University; Kasr El Aini Hospital

Completed

Bisphenol Role in the Pathogenesis of PCOS

PCOS

Egypt
University of Virginia
National Institutes of Health (NIH)

Completed

New Technology to Assess Treatment for Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

United States
Boehringer Ingelheim

Completed

In Vivo Specificity of KUC 7483 CL Co-administered With Bisoprolol, Propranolol, and Acipimox in Healthy Male Subjects

Healthy
GlaxoSmithKline

Completed

A Study to Compare the Efficacy and Safety of Fluticasone Furoate (FF) 100 mcg Once Daily With Fluticasone Propionate (FP) 250 mcg Twice Daily (BD) and FP 100 mcg BD in Well-controlled Asthmatic Japanese Subjects

Asthma

Japan
Milton S. Hershey Medical Center
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Asthma Clinical Research Network (ACRN) Trial - Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC) (TALC)

Asthma

United States
Medical University of Lodz

Completed

Comparison of Two Treatment Regimens in Asthmatic Patients

Asthma
University College Cork
Health Research Board, Ireland

Completed

The Effect of Vitamin K Supplementation on Bone Health in Adult Crohn's Disease Patients

Supplementation | Crohn's Disease | Bone Health

Ireland
Brian J Lipworth

Completed

Comparative Study of Lung Bioavailability of HFA-Seretide Via Current Spacer Devices in Healthy Volunteers

Asthma

United Kingdom
Brighton and Sussex University Hospitals NHS Trust

Terminated

PRISTINE - Personalised Approach to Improve aSThma prescrIbing iN childrEn (PRISTINE)

Asthma

United Kingdom
GlaxoSmithKline

Completed

Fluticasone Nasal Spray Patient Preference Study

Rhinitis, Allergic, Perennial

United States
National Jewish Health
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Examining the Link Between Obesity, Inflammation, and Response to Asthma Medications

Obesity | Asthma

United States
Creighton University
Roche Pharma AG

Completed

Effects of Intranasal Corticosteroid and Montelukast On Nasal Allergen Challenges* (Roche)

Allergy

United States
Parc de Salut Mar

Completed

Generation of Biological Samples Positive to Salmeterol for Anti-Doping Control (SALM)

Healthy Volunteers

Spain
West Penn Allegheny Health System

Completed

Effect of Flovent Discus vs QVAR vs Pulmicort Flexhaler on Short Term Growth

Asthma

United States
TRPHARM

Active, not recruiting

Observational Study Evaluating the Prevalence of Enzyme Deficiency in Pulmonology Clinics (ADA)

Bronchiectasis | Pulmonary Disease | Adenosine Deaminase Deficiency

Turkey
Creighton University
GlaxoSmithKline

Withdrawn

Adolescent and Adult Subjects With Asthma and Seasonal Allergic Rhinitis Receiving Advair Diskus or Placebo

Asthma | Seasonal Allergic Rhinitis

United States
Guangzhou Institute of Respiratory Disease

Unknown

ATP and Capsaicin Cough Provocation Test in Chronic Cough and Bronchiectasis

Bronchiectasis | Chronic Cough

China
University of Florida
Food and Drug Administration (FDA)

Completed

Sensitivity of Pharmacokinetics to Differences in Aerodynamic Particle Size Distribution

Asthma

United States
GlaxoSmithKline

Completed

Comparative Study of Error Rates Between ELLIPTA® Dry Powder Inhaler (DPI) and Other DPIs

Pulmonary Disease, Chronic Obstructive

Netherlands, United Kingdom
University Hospital, Bordeaux

Completed

Description of the Ability to Learn How to Handle Inhaler Devices in COPD (INTUITIVE)

Chronic Obstructive Pulmonary Disease (COPD)

France
Instituto Nacional de Ciencias Medicas y Nutricion...

Unknown

Effects of Cholecalciferol on Osteoprotegerin Levels in Patients on Peritoneal Dialysis

Renal Insufficiency | Vitamin D Deficiency | End Stage Renal Failure on Dialysis | Vascular Calcification

Mexico
University of Milan

Terminated

Bronchiectasis in Chronic Obstructive Pulmonary Disease (COPD) Patients: Role of Prophylaxis

Bronchiectasis | Pulmonary Disease | Chronic Bronchitis

Italy
Wake Forest University Health Sciences

Terminated

Nebulizer Versus Dry Powdered Inhalers for Chronic Obstructive Pulmonary Disease (COPD)

COPD | COPD Exacerbation

United States
University of Dundee

Completed

Steroid Sparing Effect of Nasal Corticosteroid In Asthma And Rhinitis

Asthma | Allergic Rhinitis

United Kingdom
Imperial College London

Completed

Pharmacokinetics of Inhaled Monodisperse Fluticasone Propionate

Healthy | Asthma

United Kingdom
Stuart Mazzone
Imperial College London; Monash University; Queen's University, Belfast

Completed

Functional Magnetic Resonance Imaging of ATP Cough in Chronic Cough Patients

Cough

Australia
Alexandrovska University Hospital

Unknown

Pharmacologic Treatment of Myocardial Ischemia Detected by Intracoronary ECG

Coronary Ischemia

Bulgaria
University of Utah

Completed

Muscle Afferent Feedback Effects in Patients With Heart Failure

Chronic Heart Failure

United States
GlaxoSmithKline

Completed

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (mcg) , FF/VI 100/25 mcg, and FF 100 mcg in Adults and Adolescents With Persistent Asthma.

Asthma

United States, Argentina, Germany, Romania, Russian Federation, Ukraine, Chile, Sweden, Mexico, Netherlands, Poland
GlaxoSmithKline

Completed

A Study of GW685698X 100mcg Administered Once Daily Either in the Morning or the Evening and GW685698X 250mcg Administered Once Daily in the Evening Via DISKHALER for 28 Days in Subjects With Persistent Bronchial Asthma.

Asthma

Germany, Romania, Bulgaria, Chile, Russian Federation, South Africa, Estonia, Italy, Mexico, Greece, Hungary, Croatia, Brazil
Merck Sharp & Dohme LLC

Completed

Induced Sputum Study (0000-065)

Asthma
Chiesi Farmaceutici S.p.A.

Completed

Study to Investigate the Effect of Formoterol vs Salmeterol on Small Airways Physiological Parameters in COPD Patients (Imperial)

Pulmonary Disease, Chronic Obstructive

United Kingdom
Associated Scientists to Help Minimize Allergies
GlaxoSmithKline; Benaroya Research Institute

Completed

Utility of Versican and Hyaluronan Measurement in Induced Sputum as Biomarkers of Asthma

Allergic Asthma

United States
GlaxoSmithKline

Completed

Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents

Asthma

United States, Germany, Romania, Poland, Belgium
St George's Healthcare NHS Trust

Unknown

Blood Markers for Inflammation and Coronary Artery Vasoreactivity Testing in Patients With Chest Pain and Normal Coronary Arteries (ACOVA)

Myocardial Ischemia | Inflammation | Atherosclerosis | Endothelial Dysfunction

United Kingdom
GlaxoSmithKline

Completed

Fluticasone Furoate/GW642444 Inhalation Powder Long-Term Safety Study

Asthma

United States, Germany, Thailand, Ukraine
GlaxoSmithKline

Completed

A Dose-ranging Study of Fluticasone Furoate (FF)

Asthma

United States, Germany, Japan, Russian Federation, Bulgaria, Peru, Philippines, Poland, Mexico, Ukraine, Sweden, South Africa, Latvia, Puerto Rico, Georgia
GlaxoSmithKline

Completed

Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive

United States, Argentina, Japan, Poland, Romania, Russian Federation, Spain, Ukraine, Germany, Taiwan, Bulgaria, Hungary, France, Philippines, South Africa, Thailand, Israel, Korea, Republic of, Australia, Mexico, Slovakia, United... and more
GlaxoSmithKline

Completed

Asthma Exacerbation Study

Asthma

United States, Argentina, Germany, Japan, Poland, Romania, Russian Federation, Mexico, Ukraine, Australia, Philippines
GlaxoSmithKline

Completed

Study to Look at and Compare How Inhaled and Intravenous Fluticasone Furoate and GW642444 Are Processed by the Body in Healthy Subjects

Asthma

Australia
GlaxoSmithKline

Completed

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

Asthma

Russian Federation, United States, Peru, Mexico, Netherlands, Poland
GlaxoSmithKline

Completed

Study HZA106829: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics

Asthma

United States, Germany, Japan, Romania, Russian Federation, Poland
GlaxoSmithKline

Completed

Dose Proportionality Study: Blood Levels of Fluticasone Furoate (FF) and Vilanterol (VI) Following Different Doses of FF/VI Via an Inhaler

Asthma

United Kingdom
Mahidol University

Recruiting

As Needed Versus Regular Intranasal Corticosteroid in Children With Perennial Allergic Rhinitis

Perennial Allergic Rhinitis | Child, Only

Thailand
GlaxoSmithKline

Completed

Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS

Rhinitis, Allergic, Perennial

United States
Morten Hostrup, PhD

Recruiting

U-LABA/ICS Effects on Exercise Performance, Vilanterol

Exercise Performance

Denmark
Teva Pharmaceuticals USA

Terminated

Clinical Equivalence Study of Fluticasone Propionate Nasal Spray, 50 mcg/Actuation vs. Flonase in Allergic Rhinitis Patients

Seasonal Allergic Rhinitis

United States
SkyePharma AG
Abbott; MDS Pharma Services

Completed

A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiForm™) With Fluticasone or Flovent to Treat Moderate to Severe Asthma in Adolescents and Adults

Asthma

United States, Chile, Mexico, Peru, Romania, Hungary, South Africa, Ukraine, Poland, Argentina
GlaxoSmithKline

Completed

Pharmacokinetic and Pharmacodynamic (PK and PD) Study of Fluticasone Propionate and Salmeterol Combination Product Delivered in a Capsule-based Inhaler and in a Multi-dose Dry Powder Inhaler in Moderate Asthma Patients and Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients.

Asthma

Australia, New Zealand
GlaxoSmithKline

Completed

Inhaled Fluticasone Furoate/Vilanterol Safety and Tolerability, PK and PD Study

Asthma

United States

3

Subscribe